Mutual funds are subject to market risk. Read all scheme documents carefully.
This fund is not currently rated by our system. However, we continuously review and update our ratings, so it may be included in the future.
Our score weighs long-term performance, risk and consistency — not just past returns.
As of 4 Nov 2026
As of 31 Oct 2026
Long term capital growth. Investment in equity and equity related securities of companies operating with pioneering innovations theme without any market capitalisation and sector bias.
The scheme seeks to generate capital appreciation from a diversified portfolio of equity, equity related instruments and units of global mutual funds which invests into such companies that utilize new forms of production, technology, distribution or processes which are likely to challenge existing markets or value networks, or displace established market leaders, or bring in novel products and/or business models.
0.5% for redemption within 90 Days

As of 30 Sep 2026
| Holding | % of fund | Value | Shares |
|---|---|---|---|
| iShares NASDAQ 100 UCITS ETF USD | 16.33% | ₹701.11 Cr | 41,550 |
| Eternal Ltd. | 5.53% | ₹237.55 Cr | 74,23,324 |
| INDO-MIM Ltd. | 4.92% | ₹211.22 Cr | 17,00,000 |
| Lenskart Solutions Ltd. | 3.65% | ₹156.82 Cr | 22,89,184 |
| Aster DM Quality Care Ltd. | 2.94% | ₹126.21 Cr | 18,10,427 |
| Aditya Infotech Ltd. | 2.90% | ₹124.73 Cr | 3,24,277 |
| ICICI Bank Ltd. | 2.66% | ₹114.33 Cr | 8,65,000 |
| Interglobe Aviation Ltd. | 2.41% | ₹103.42 Cr | 2,07,500 |
| Capillary Technologies India Ltd. | 2.15% | ₹92.51 Cr | 16,50,570 |
| Bharti Hexacom Ltd. | 2.05% | ₹88.21 Cr | 6,19,250 |